SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-23-000061
Filing Date
2023-08-10
Accepted
2023-08-10 16:13:50
Documents
43
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20230630.htm   iXBRL 10-Q 524457
2 EX-31.1 slrx20230630ex-311.htm EX-31.1 8861
3 EX-31.2 slrx20230630ex-312.htm EX-31.2 8651
4 EX-32.1 slrx20230630ex-321.htm EX-32.1 6366
  Complete submission text file 0001615219-23-000061.txt   2969936

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230630.xsd EX-101.SCH 21858
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20230630_cal.xml EX-101.CAL 25285
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20230630_def.xml EX-101.DEF 94800
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230630_lab.xml EX-101.LAB 329568
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230630_pre.xml EX-101.PRE 204591
37 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230630_htm.xml XML 246666
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 231159534
SIC: 2834 Pharmaceutical Preparations